MANUEL EDUARDO
MUÑOZ TORRES
CATEDRÁTICO DE UNIVERSIDAD
Complejo Hospitalario Torrecárdenas de Almería
Almería, EspañaPublicaciones en colaboración con investigadores/as de Complejo Hospitalario Torrecárdenas de Almería (12)
2022
-
Differential inflammatory environment in patients with osteoporosis and type 2 diabetes mellitus
Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 34-41
2021
-
Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition
Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276
2019
-
Factors predicting the response to a vitamin D-fortified milk in healthy postmenopausal women
Nutrients, Vol. 11, Núm. 11
2018
-
Effects of Daily Intake of Calcium and Vitamin D-Enriched Milk in Healthy Postmenopausal Women: A Randomized, Controlled, Double-Blind Nutritional Study
Journal of Women's Health, Vol. 27, Núm. 5, pp. 561-568
-
High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis
Clinical Endocrinology, Vol. 89, Núm. 4, pp. 414-423
-
Higher Levels of Serum 25-Hydroxyvitamin D Are Related to Improved Glucose Homeostasis in Women with Postmenopausal Osteoporosis
Journal of Women's Health, Vol. 27, Núm. 8, pp. 1007-1015
2017
-
Recommendations on the effect of antidiabetic drugs in bone
Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 1-6
-
Recommended vitamin D levels in the general population
Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 7-14
2012
-
Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate
Menopause, Vol. 19, Núm. 2, pp. 172-177
2010
-
Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor κb in women with postmenopausal osteoporosis
Menopause, Vol. 17, Núm. 1, pp. 140-144
2009
-
Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate
Maturitas, Vol. 64, Núm. 3, pp. 188-192
2004
-
Susceptibility for postmenopausal osteoporosis: Interaction between genetic, hormonal and lifestyle factors
Calcified Tissue International, Vol. 75, Núm. 5, pp. 373-379